Akl LD, Valadares ALR, Gomes DC, Pinto-Neto AM and Costa-Paiva L
Metabolic Syndrome is associated with an increased risk of cardiovascular disease, increases after menopause and it is probably more frequent in HIV women.
Objective: To assess MetS and associated factors in HIV seropositive and seronegative middle-aged women.
Methods: Cross-sectional study with 537 women (273 HIV seropositive and 264 HIV seronegative), between 40 and 60 years’ old receiving follow-up care in two medical centers in Brazil. MetS was diagnosed based on IDF criteria. Sociodemographic, clinical, and behavioral factors were evaluated.
Results: The prevalence of MetS in the HIV group was 46.9% and 42.2% in the seronegative group (P=0.340). Multiple regression analysis showed MetS association with body mass index (BMI)>25 kg/m² (PR=2.34; 95% CI: 1.70- 3.21; P<0.001), aging (PR: 0.05, 95% CI: 1.02-1.07; P<0.001), and the use of highly active retroviral therapy (HAART) (PR: 1.48; 95% CI: 1.13-1.94; P=0.005). Conclusions: There was no association between MetS and HIV status overall. Although HAART was associated with MetS, it seems that HIV-positive women in good immunological status, after early institution of HAART and its effective use, have traditional factors associated with MetS like being overweight and having older age.
இந்தக் கட்டுரையைப் பகிரவும்
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 